Jump to content

Alloderm

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Ensadvocate (talk | contribs) at 22:06, 13 June 2016 (→‎Legal issues with Alloderm and hernia repair: made more clear what is relationship between Lifecell and alloderm). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Alloderm is an ECM Biomaterial used in medicine.[1] Alloderm is marketed by and a registered trademark of the LifeCell Corporation based in Bridgewater, NJ[2]. Alloderm has been used to reconstruct breasts experimentally after breast cancer surgery.[3] Alloderm has been used as a gingival graft in periodontics; when using Alloderm, there is no need for a palatal donor site [4] Alloderm has been used for abdominal hernia repair.[5] Alloderm has been used in otorhinolaryngology as implants to rebuild resected turbinates in the treatment of Empty nose syndrome.[6]

As of April 17, 2014 there was 330 lawsuits Against Lifecell the marketer of Alloderm, consolidated in New Jersey State Court (USA) before Superior Court Judge Jessica R. Mayer. All the Lawsuits in the state of new jersey involve complications due to usage of alloderm for hernia repair and/or AlloDerm reconstructive surgery. It has been Alleged that lifecell has been aggressively marketing Alloderm, for off label uses of Alloderm including hernia repair. None of the lawsuits involve burn victims or those who may have received AlloDerm by LifeCell for periodontal surgery.[7]

References

  1. ^ "LifeCell: AlloDerm® Tissue Matrix defined". www.lifecell.com. Retrieved 2016-06-10.
  2. ^ "Acelity - ALLODERM SELECT™ Regenerative Tissue Matrix". www.lifecell.com. Retrieved 2016-06-12.
  3. ^ Salzberg, C. Andrew (2006-07-01). "Nonexpansive immediate breast reconstruction using human acellular tissue matrix graft (AlloDerm)". Annals of Plastic Surgery. 57 (1): 1–5. doi:10.1097/01.sap.0000214873.13102.9f. ISSN 0148-7043. PMID 16799299.
  4. ^ Hirsch A, Goldstein M, Goultschin J, Boyan BD, Schwartz Z (2005). "A 2-year follow-up of root coverage using sub-pedicle acellular dermal matrix allografts and subepithelial connective tissue autografts". Journal of Periodontology. 76 (8): 1323–8. doi:10.1902/jop.2005.76.8.1323. PMID 16101365.
  5. ^ Misra, S.; Raj, P. K.; Tarr, S. M.; Treat, R. C. (2008-06-01). "Results of AlloDerm use in abdominal hernia repair". Hernia: The Journal of Hernias and Abdominal Wall Surgery. 12 (3): 247–250. doi:10.1007/s10029-007-0319-z. ISSN 1265-4906. PMID 18209948.
  6. ^ Leong SC. The clinical efficacy of surgical interventions for empty nose syndrome: A systematic review. Laryngoscope. 2015 Jul;125(7):1557-62. Review. PMID 25647010
  7. ^ Gibb, Gordon. "AlloDerm Infection Plaintiffs Look to September 2015 As a Beginning". Lawyers and settlements. LawyersandSettlements.com. Retrieved 13 June 2016.